Categories: News

Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN JOSE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) — Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2024 after the close of trading on Wednesday, February 19, 2025.

On the same day, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Nabeel Ahmed, Chief Financial Officer, will host a conference call to discuss financial and operating results.

Conference Call Details
The conference call will begin at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) on Wednesday, February 19, 2025. Those interested in joining the conference call may do so by registering online. Once registered, participants will receive dial-in numbers and a unique pin to join the call. Participants are encouraged to register more than 15 minutes before the start of the call. A live and archived webcast of the event will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.

About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contact
Jim Mazzola
Investor Relations
jmazzola@outsetmedical.com

Staff

Recent Posts

As Pilgrims Arrive in Makkah, Saudi Arabia Rolls Out Massive Operation to Safeguard Health

Massive health operation for world's largest religious gathering with 111,400 health services already delivered. 111,400…

24 minutes ago

Mark A. Davis, MD, MS Joins X Boson Inc. Board to Drive Strategy, Innovation, and Healthcare System Integration in AI-Powered Medication Management

Healthcare executive and physician brings decades of healthcare leadership, growth, and operational success to scale…

24 minutes ago

Leaders from Sharp HealthCare and MCG Discuss AI-Driven Utilization Management Success at CMSA 2025

Care management experts will discuss the benefits of leveraging new technologies to reduce hospital administrative…

24 minutes ago

CaringBridge and DoorDash Partner for Two-Day Fundraising Match to Support Family Caregivers

BLOOMINGTON, Minn. and SAN FRANCISCO, June 5, 2025 /PRNewswire/ -- CaringBridge, the nonprofit health communication platform,…

24 minutes ago

HealthVerity and Medeloop Announce Strategic Partnership to Enhance Real-World Evidence Insights with AI-Driven Analytics

PHILADELPHIA and MENLO PARK, Calif., June 5, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world…

24 minutes ago